Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours

Cell Proliferation

Volumn 29, Issue 3, 1996, Pages 141-152

  Wilson, G D ^a,c   Saunders, M I ^b   Dische, S ^b   Daley, F M ^b   Robinson, B M ^b   Martindale, C A ^a   Joiner, B ^a   Richman, P I ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b WEST HERTFORDSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CELL NUCLEUS ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ARTICLE; CELL CYCLE S PHASE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE LABELING; LABELING INDEX; TUMOR;

EID: 0029902599     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.1996.tb00101.x     Document Type: Article

References (29)

1. BEGG AC, MCNALLY NJ, SHRIEVE DC, KĀRCHER H. (1985) A method to measure the DNA synthesis and the potential doubling time from a single sample. Cytometry 6, 620.
2. BEGG AC, HOFLAND I, VAN GLABBEKE M, BARTLELINK H, HORIOT J-C. (1992) Predictive value of potential doubling time for radiotherapy of head and neck tumour patients: results from the EORTC co-operative trial 22851. Semin. Radiat. Oncol. 2, 22.
3. BENNETT MH, WILSON GD, DISCHE S et al. (1992) Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer 65, 870.
4. BOURHIS J, WILSON GD, WIBAULT P et al. (1993) In vivo measurement of the potential doubling time by flow cytometry in oropharyngeal cancer treated by conventional radiotherapy. In. J. Radiat. Oncol. Biol. Phys. 26, 793.
5. BROWN DC, GATTER KC. (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 25, 31.
6. CORVO R, GIARETTI W, SANGUINETI G et al. (1995). In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J. Clin. Oncol 13, 1843.
7. COSTA A, SALVATORI P, MOLINARA R, MOTTA R, CERUTTI A, SILVESTRINI R. (1986) Cell kinetics to monitor radioresponsivity in human epidermoid carcinoma. Basic Applied Histochemistry, 30, 209.
8. DUCHROW M, GERDES J, SCHLÜTER. (1994) The proliferation-associated Ki-67 protein: definition in molecular terms. Cell Prolif. 27, 235.
9. GERDES J, SCHWAB U, LEMKE H, STEIN H. (1983) Production of a mouse monoclonal antibody relative with a human clear antigen associated with cell proliferation. Br. J. Cancer 31, 13.
10. HALL PA, COATES PJ, GOODLAD RA, HART IR, LANE DP. (1993) Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo. Br. J. Cancer 70, 244.
11. HALL PA, WOODS AL. (1990) Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet. 23, 505.
12. KEY G, BECKER MHG, BARON B et al. (1993) New Ki-67 equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 66 bp repetitive elements encoding for the Ki-67 epitope. Lab. Invest. 68, 629.
13. KREIPE H, HEIDEBRECHT HJ, HANSEN S et al. (1993) A new proliferation associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1. Am. J. Pathol. 142, 3.
14. MCCORMICK D, YU C, HOBBS C, HALL PA. (1993) The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology 22, 543.
15. MANN GJ, DYNE M, MUSOROVE EA. (1987) Immunofluorescent quantification of ribonucleotide reductase M1 subunit and correlation with DNA content by flow cytometry. Cytometry 8, 509.
16. MIYACHI K, FRITZLER MJ, TAN EM. (1978) Autoantibody to a nuclear antigen in proliferating cells. J. Immunol. 121, 2228.
17. SASAKI K, MURAKAMI T, KAWASAKI M, TAKAHASHI M. (1987) The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. J. Cell Physiol 133, 579.
18. SCHLÜTER C, DUCHROW M, WOHLENBERG C et al. (1993) The cell proliferation-associated antigen of antibody Ki-67: a very large ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintained proteins. J. Cell Biol 123, 513.
19. SCOTT RJ, HALL PA, HALDANE JS et al. (1991) A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fractions. J. Path 165, 173.
20. SHIVJI KK, KENNY MK, WOOD RD. (1992) Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69, 367.
21. VALENTE G, ORECCHIA R, GANDOLFO S et al. (1994) Can Ki-67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma? J. Clin. Pathol. 47, 109.
22. VERHEIJEN R, KUIJPERS HJH, VAN DRIEL R et al. (1989) Ki-67 detects a nuclear matrix associated proliferation antigen. Part II. Localisation in mitotic cells and association with chromosomes. J. Cell Sci. 92, 531.
23. WASEEM NH, LANE DP. (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J. Cell. Sci. 96, 121.
24. WILSON GD. (1991) Assessment of human tumour proliferation using bromodeoxyuridine: current status. Acta Oncologica 30, 903.
25. WILSON GD, DISCHE S, SAUNDERS ML. (1995) Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Rdiother. & Oncol. 36, 189.
26. WILSON GD, MCNALLY NJ, DISCHE S et al. (1988) Measurement of cell kinetics in human tumours in vivo, using bromodeoxyuridine incorporation and flow cytometry. Br. J. Cancer 58, 423.
27. WILSON GD, MCNALLY NJ, DUNPHY E, PFRAGNER P, KĀRCHER H. (1985) The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vivo and in vitro and flow cytometry. Cytometry 6, 641.
28. YAMAGUCHI A, TAKEGAWA AS, ISHIDA T et al. (1990) Detection of the growth fraction in colorectal tumours by a monoclonal antibody against DNA polymerase-α. Br. J. Cancer 61, 390.
29. YU CCW, FILIPE MI. (1993) Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochemical J 25, 843.